Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Candidiasis | Research

Vitamin D deficiency and oral candidiasis in patients with HIV infection: A case‒control study

Authors: Shabnam Tehrani, Ladan Abbasian, Seyed Ali Dehghan Manshadi, Malihe Hasannezhad, Sara Ghaderkhani, Amirreza Keyvanfar, Azar Darvishi, AmirHossein Aghdaee

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Oral candidiasis is a common opportunistic infection in patients with human immunodeficiency virus (HIV). In addition, most of these patients suffer from vitamin D deficiency. This study aimed to investigate the association between vitamin D levels and oral candidiasis in patients with HIV infection.

Methods

This case‒control study was conducted on HIV-infected patients. Cases were patients with oral candidiasis diagnosed based on physical examinations. Controls were age- and sex-matched individuals without oral candidiasis. The levels of 25-OH vitamin D and other laboratory markers (CD4 count and viral load) were compared between the case and control groups.

Results

A total of 104 cases and 102 controls were included in the study. The cases had significantly lower 25-OH vitamin D3 levels (MD = 33.86 ng/mL, 95% CI= (31.85, 35.87), P < 0.001) and CD4 counts (MD = 267.48 cells/mm3, 95% CI= (189.55, 345.41), P < 0.001) than the controls. In addition, viral load was significantly higher in cases than in controls (MD = 7.03 × 105 copies/mL, 95% CI= (4.46 × 105, 9.61 × 105), P < 0.001). The multivariate logistic regression analysis revealed that educational status (OR = 0.032, 95% CI= (0.002, 0.100), P < 0.001), current HAART (OR = 0.005, 95% CI= (0.001, 0.014), P < 0.001), history of oral candidiasis (OR = 20.114, 95% CI= (18.135, 21.957), P < 0.001), CD4 count (OR = 0.004, 95% CI= (0.001, 0.006), P < 0.001), viral load (OR = 12.181, 95% CI= (1.108, 133.392), P < 0.001), and vitamin D level (OR = 0.011, 95% CI= (0.008, 0.015), P < 0.001) were significantly associated with the risk of developing oral candidiasis.

Conclusions

Based on the findings, most patients with HIV infection suffer from vitamin D deficiency, especially those with oral candidiasis. Hypovitaminosis D was significantly associated with an increased risk of oral candidiasis. Thus, vitamin D supplementation may assist HIV-positive patients in improving their oral health and preventing oral candidiasis.
Literature
2.
go back to reference Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a Disease of Opportunity. J fungi (Basel Switzerland). 2020;6(1). Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a Disease of Opportunity. J fungi (Basel Switzerland). 2020;6(1).
3.
go back to reference Shekatkar M, Kheur S, Gupta AA, Arora A, Raj AT, Patil S, et al. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy. Dis Mon. 2021;67(9):101169.CrossRefPubMed Shekatkar M, Kheur S, Gupta AA, Arora A, Raj AT, Patil S, et al. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy. Dis Mon. 2021;67(9):101169.CrossRefPubMed
4.
go back to reference Nittayananta W. Oral fungi in HIV: challenges in antifungal therapies. Oral Dis. 2016;22(Suppl 1):107–13.CrossRefPubMed Nittayananta W. Oral fungi in HIV: challenges in antifungal therapies. Oral Dis. 2016;22(Suppl 1):107–13.CrossRefPubMed
5.
go back to reference Ambe NF, Longdoh NA, Tebid P, Bobga TP, Nkfusai CN, Ngwa SB, et al. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Pan Afr Med J. 2020;36:23.CrossRefPubMedPubMedCentral Ambe NF, Longdoh NA, Tebid P, Bobga TP, Nkfusai CN, Ngwa SB, et al. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Pan Afr Med J. 2020;36:23.CrossRefPubMedPubMedCentral
6.
go back to reference Suryana K, Suharsono H, Antara I. Factors Associated with oral candidiasis in People Living with HIV/AIDS: a Case Control Study. HIV/AIDS (Auckland NZ). 2020;12:33–9. Suryana K, Suharsono H, Antara I. Factors Associated with oral candidiasis in People Living with HIV/AIDS: a Case Control Study. HIV/AIDS (Auckland NZ). 2020;12:33–9.
7.
go back to reference Mehta S, Mugusi FM, Spiegelman D, Villamor E, Finkelstein JL, Hertzmark E, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDs. 2011;25(10):579–85.CrossRefPubMedPubMedCentral Mehta S, Mugusi FM, Spiegelman D, Villamor E, Finkelstein JL, Hertzmark E, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDs. 2011;25(10):579–85.CrossRefPubMedPubMedCentral
8.
go back to reference Kim JH, Gandhi V, Psevdos G Jr., Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses. 2012;28(3):235–41.CrossRefPubMed Kim JH, Gandhi V, Psevdos G Jr., Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses. 2012;28(3):235–41.CrossRefPubMed
9.
go back to reference Deshwal R, Arora S. High prevalence of vitamin D Deficiency in HIV infected on antiretroviral therapy in a cohort of Indian patients. J Assoc Phys India. 2019;67(3):42–5. Deshwal R, Arora S. High prevalence of vitamin D Deficiency in HIV infected on antiretroviral therapy in a cohort of Indian patients. J Assoc Phys India. 2019;67(3):42–5.
11.
go back to reference Lee S, Lee JE, Lee SO, Sim YK, Lee SH. Influence of vitamin D Deficiency on the development of opportunistic infection in People Living with HIV/AIDS (PWHAs). J Am Coll Nutr. 2021;40(6):545–50.CrossRefPubMed Lee S, Lee JE, Lee SO, Sim YK, Lee SH. Influence of vitamin D Deficiency on the development of opportunistic infection in People Living with HIV/AIDS (PWHAs). J Am Coll Nutr. 2021;40(6):545–50.CrossRefPubMed
12.
go back to reference Sroussi HY, Burke-Miller J, French AL, Adeyemi OM, Weber KM, Lu Y, et al. Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. J Dent Res. 2012;91(7):666–70.CrossRefPubMedPubMedCentral Sroussi HY, Burke-Miller J, French AL, Adeyemi OM, Weber KM, Lu Y, et al. Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. J Dent Res. 2012;91(7):666–70.CrossRefPubMedPubMedCentral
13.
go back to reference Branson BM, Owen SM, Wesolowski LG, Bennett B, Werner BG, Wroblewski KE et al. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014. Branson BM, Owen SM, Wesolowski LG, Bennett B, Werner BG, Wroblewski KE et al. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014.
14.
go back to reference Nikolopoulos GK, Tsantes AG, Recent HIV, Infection. Diagnosis and Public Health Implications. Diagnostics (Basel Switzerland). 2022;12(11). Nikolopoulos GK, Tsantes AG, Recent HIV, Infection. Diagnosis and Public Health Implications. Diagnostics (Basel Switzerland). 2022;12(11).
15.
go back to reference Coronado-Castellote L, Jiménez-Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J Clin Experimental Dentistry. 2013;5(5):e279.CrossRef Coronado-Castellote L, Jiménez-Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J Clin Experimental Dentistry. 2013;5(5):e279.CrossRef
16.
go back to reference Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, et al. High prevalence of vitamin D Deficiency among Iranian Population: a systematic review and Meta-analysis. Iran J Med Sci. 2018;43(2):125–39.PubMedPubMedCentral Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, et al. High prevalence of vitamin D Deficiency among Iranian Population: a systematic review and Meta-analysis. Iran J Med Sci. 2018;43(2):125–39.PubMedPubMedCentral
17.
go back to reference Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AJ, Lomelí-Martínez MA, Martínez-Salazar SY, Mercado González AE et al. Oral manifestations Associated with HIV/AIDS patients. Med (Kaunas Lithuania). 2022;58(9). Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AJ, Lomelí-Martínez MA, Martínez-Salazar SY, Mercado González AE et al. Oral manifestations Associated with HIV/AIDS patients. Med (Kaunas Lithuania). 2022;58(9).
18.
go back to reference Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining challenges. Curr HIV/AIDS Rep. 2020;17(1):26–34.CrossRefPubMedPubMedCentral Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining challenges. Curr HIV/AIDS Rep. 2020;17(1):26–34.CrossRefPubMedPubMedCentral
19.
go back to reference Vohra P, Jamatia K, Subhada B, Tiwari RVC, Althaf MN, Jain C. Correlation of CD4 counts with oral and systemic manifestations in HIV patients. J Family Med Prim care. 2019;8(10):3247–52.CrossRefPubMedPubMedCentral Vohra P, Jamatia K, Subhada B, Tiwari RVC, Althaf MN, Jain C. Correlation of CD4 counts with oral and systemic manifestations in HIV patients. J Family Med Prim care. 2019;8(10):3247–52.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Gonçalves LS, Júnior AS, Ferreira SM, Sousa CO, Fontes TV, Vettore MV, et al. Factors associated with specific clinical forms of oral candidiasis in HIV-infected Brazilian adults. Arch Oral Biol. 2013;58(6):657–63.CrossRefPubMed Gonçalves LS, Júnior AS, Ferreira SM, Sousa CO, Fontes TV, Vettore MV, et al. Factors associated with specific clinical forms of oral candidiasis in HIV-infected Brazilian adults. Arch Oral Biol. 2013;58(6):657–63.CrossRefPubMed
22.
go back to reference Steenhoff AP, Schall JI, Samuel J, Seme B, Marape M, Ratshaa B, et al. Vitamin D3supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial. PLoS ONE. 2015;10(2):e0117123.CrossRefPubMedPubMedCentral Steenhoff AP, Schall JI, Samuel J, Seme B, Marape M, Ratshaa B, et al. Vitamin D3supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial. PLoS ONE. 2015;10(2):e0117123.CrossRefPubMedPubMedCentral
23.
go back to reference Mumena CH, Mudhihiri MH, Sasi R, Mlawa M, Nyerembe S, Akimbekov NS, et al. The relevance of vitamin D in the oral health of HIV infected patients. J Steroid Biochem Mol Biol. 2021;211:105905.CrossRefPubMed Mumena CH, Mudhihiri MH, Sasi R, Mlawa M, Nyerembe S, Akimbekov NS, et al. The relevance of vitamin D in the oral health of HIV infected patients. J Steroid Biochem Mol Biol. 2021;211:105905.CrossRefPubMed
24.
go back to reference Sudfeld CR, Duggan C, Aboud S, Kupka R, Manji KP, Kisenge R, et al. Vitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants. J Nutr. 2015;145(1):121–7.CrossRefPubMed Sudfeld CR, Duggan C, Aboud S, Kupka R, Manji KP, Kisenge R, et al. Vitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants. J Nutr. 2015;145(1):121–7.CrossRefPubMed
25.
go back to reference Gu Y, Baldwin S, Canning C, Hypovitaminosis D. Objective oral dryness, and fungal hyphae as three precipitating factors for a subset of secondary burning mouth syndrome. Heliyon. 2023;9(9):e19954.CrossRefPubMedPubMedCentral Gu Y, Baldwin S, Canning C, Hypovitaminosis D. Objective oral dryness, and fungal hyphae as three precipitating factors for a subset of secondary burning mouth syndrome. Heliyon. 2023;9(9):e19954.CrossRefPubMedPubMedCentral
Metadata
Title
Vitamin D deficiency and oral candidiasis in patients with HIV infection: A case‒control study
Authors
Shabnam Tehrani
Ladan Abbasian
Seyed Ali Dehghan Manshadi
Malihe Hasannezhad
Sara Ghaderkhani
Amirreza Keyvanfar
Azar Darvishi
AmirHossein Aghdaee
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09065-x

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine